Natural Product Group Sues to Block FDA Drug Exclusion Meaning

A natural product trade association is challenging the FDA’s interpretation of what counts as a dietary supplement, alleging the agency erroneously excluded a product and misinterpreted a federal law.

The Food and Drug Administration incorrectly classified ß-Nicotinamide Mononucleotide (NMN) when it excluded it from the definition of dietary supplement under the Dietary Supplement Health and Education Act’s drug exclusion clause, the Natural Products Association wrote in a complaint Wednesday before the US District Court for the District of Columbia.

The law, which establishes a regulatory framework for dietary supplements in the US, includes a clause that excludes ingredients that are ...